Inmune Bio, Inc.
Recent Filings
All 578 filings →| Form | Description | Date |
|---|---|---|
| 8-K | CURRENT REPORT | Feb 27, 2026 |
| 8-K | CURRENT REPORT | Feb 23, 2026 |
| 8-K | CURRENT REPORT | Feb 19, 2026 |
| 8-K | CURRENT REPORT | Feb 13, 2026 |
| 8-K | CURRENT REPORT | Jan 27, 2026 |
| 8-K | CURRENT REPORT | Dec 23, 2025 |
| 8-K | CURRENT REPORT | Dec 19, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | Dec 19, 2025 |
| 8-K | CURRENT REPORT | Dec 10, 2025 |
| 8-A12B/A | AMENDMENT NO. 5 TO FORM 8-A12B | Dec 8, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Moss David J | Chief Financial Officer | Purchase | 10,000 @ $5.29 | 1,285,869 | Sep 30, 2024 |
| Tesi Raymond Joseph | President and CEO | Purchase | 15,380 @ $6.38 | 1,554,106 | Sep 12, 2024 |
| Moss David J | Chief Financial Officer | Purchase | 7,690 @ $6.38 | 1,275,869 | Sep 12, 2024 |
| Juda Scott | — | Purchase | 5,000 @ $7.27 | 71,603 | Jun 25, 2024 |
| Moss David J | CFO, Treasurer & Secretary | Purchase | 18,028 @ $8.32 | 1,268,179 | Apr 19, 2024 |
| Tesi Raymond Joseph | President and CEO | Purchase | 18,028 @ $8.32 | 1,538,726 | Apr 19, 2024 |
| Lowdell Mark William | Chief Scientific Officer | Purchase | 14,423 @ $8.32 | 1,510,806 | Apr 19, 2024 |
| Juda Scott | — | Purchase | 29,603 @ $8.32 | 66,603 | Apr 19, 2024 |
| Tesi Raymond Joseph | President and CEO | Award / Grant | 18,028 @ $8.32 | 1,538,726 | Apr 19, 2024 |
| Moss David J | CFO, Treasurer & Secretary | Award / Grant | 18,028 @ $8.32 | 1,268,179 | Apr 19, 2024 |